Sign Up to like & get
recommendations!
0
Published in 2017 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-017-0509-6
Abstract: Opinion statementMost patients with hepatocellular carcinoma present with intermediate to advanced disease, where curative therapies are no longer an option. These patients with intermediate to advanced disease represent a heterogeneous population with regard to tumor…
read more here.
Keywords:
hepatocellular carcinoma;
bclc disease;
ctace;
disease ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "International Journal of Hyperthermia"
DOI: 10.1080/02656736.2022.2051613
Abstract: Abstract Objectives Recurrent hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI)-positive primary tumor is at high risk of re-recurrence while treated with radiofrequency ablation (RFA). We aimed to investigate whether neoadjuvant conventional transarterial chemoembolization (cTACE)…
read more here.
Keywords:
recurrent hepatocellular;
group;
recurrence;
ctace ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Applied Bionics and Biomechanics"
DOI: 10.1155/2022/9084852
Abstract: Background Transarterial chemoembolization (TACE) is the most common treatment for patients with HCC who are unsuitable for radical therapies. Conventional TACE (cTACE) takes advantage of the preferential hepatic arterial supply of HCC for the targeted…
read more here.
Keywords:
h101 tace;
unresectable hepatocellular;
hcc;
tace ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical and translational gastroenterology"
DOI: 10.14309/ctg.0000000000000506
Abstract: INTRODUCTION Patients with unresectable hepatocellular carcinoma treated with conventional transarterial chemoembolization (cTACE) have heterogeneous tumor burden and liver function. Therefore, the selection of patients for repeated cTACE is challenging owing to different outcomes. This study…
read more here.
Keywords:
hepatocellular carcinoma;
score;
risk;
ctace ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Translational cancer research"
DOI: 10.21037/27314
Abstract: Background: This study evaluated the safety and efficacy of transcatheter chemoembolization with drug eluting beads (DEB-TACE) and compared it to the conventional TACE (cTACE) therapy method for hepatocellular carcinoma (HCC) in Chinese patients. Methods: Seventy-four…
read more here.
Keywords:
hepatocellular carcinoma;
tace;
response;
deb tace ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Korean Journal of Radiology"
DOI: 10.3348/kjr.2018.19.6.1130
Abstract: Objective To compare the therapeutic efficacy between conventional transarterial chemoembolization (cTACE) and combined therapy using cTACE and radiofrequency ablation (RFA) in ultrasound (US)-invisible early stage hepatocellular carcinoma (HCC). Materials and Methods From January 2008 to…
read more here.
Keywords:
chemoembolization;
ctace;
group;
early stage ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Applied Sciences"
DOI: 10.3390/app10207337
Abstract: Transarterial chemoembolization (TACE) is a first-line treatment for patients with hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer stage B (BCLC-B). There are two major techniques of TACE: conventional TACE (cTACE) using iodized oil and…
read more here.
Keywords:
hepatocellular carcinoma;
tace;
hcc;
ctace ... See more keywords